Curated public policy issues for AMITA Health's physician partners.
Surprise medical billing is a widespread and costly problem in the U.S. and there is bipartisan support that patients should not be subject to surprise medical bills over which they had no control. The COVID-19 pandemic underscores the urgency of addressing the issue and illustrates that action on surprise billing is possible.
Medicare COVID-19 IPPS Add-on Guidance
On August 17, 2020 CMS issued a new requirement related to the 20% inpatient prospective payment system (IPPS) diagnosis-related group (DRG) rate add-on for patients diagnosed with COVID-19. For inpatient admissions occurring on or after Sept. 1, 2020, claims eligible for the 20% add-on will be required to have a positive COVID-19 laboratory test documented in patients’ medical records.